Allworth Financial’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.4K Hold
790
﹤0.01% 2438
2026
Q1
$42.7K Hold
790
﹤0.01% 2439
2025
Q4
$44.2K Hold
790
﹤0.01% 2282
2025
Q3
$37.9K Hold
790
﹤0.01% 2296
2025
Q2
$32.1K Hold
790
﹤0.01% 2212
2025
Q1
$31.5K Hold
790
﹤0.01% 1797
2024
Q4
$35.2K Hold
790
﹤0.01% 1763
2024
Q3
$35K Hold
790
﹤0.01% 1571
2024
Q2
$32.8K Hold
790
﹤0.01% 1576
2024
Q1
$34.1K Sell
790
-150
-16% -$6.46K ﹤0.01% 1474
2023
Q4
$39.1K Hold
940
﹤0.01% 1292
2023
Q3
$37.4K Hold
940
﹤0.01% 1225
2023
Q2
$38.5K Hold
940
﹤0.01% 1217
2023
Q1
$38.5K Hold
940
﹤0.01% 1170
2022
Q4
$38.5K Hold
940
﹤0.01% 1117
2022
Q3
$38K Hold
940
﹤0.01% 1059
2022
Q2
$39K Hold
940
﹤0.01% 991
2022
Q1
$43K Hold
940
﹤0.01% 952
2021
Q4
$43K Hold
940
﹤0.01% 886
2021
Q3
$45K Buy
940
+790
+527% +$39.3K ﹤0.01% 812
2021
Q2
$8K Hold
150
﹤0.01% 1114
2021
Q1
$8K Hold
150
﹤0.01% 1044
2020
Q4
$8K Hold
150
﹤0.01% 900
2020
Q3
$7K Hold
150
﹤0.01% 792
2020
Q2
$6K Hold
150
﹤0.01% 841
2020
Q1
$5K Hold
150
﹤0.01% 891
2019
Q4
$7K Hold
150
﹤0.01% 717
2019
Q3
$5K Hold
150
﹤0.01% 694
2019
Q2
$6K Hold
150
﹤0.01% 665
2019
Q1
$6K Hold
150
﹤0.01% 659
2018
Q4
$5K Hold
150
﹤0.01% 624
2018
Q3
$7K Hold
150
﹤0.01% 613
2018
Q2
$6K Hold
150
﹤0.01% 612
2018
Q1
$6K Hold
150
﹤0.01% 571
2017
Q4
$7K Hold
150
﹤0.01% 529
2017
Q3
$6K Hold
150
﹤0.01% 560
2017
Q2
$6K Buy
+150
New +$6.32K ﹤0.01% 557

Other funds holding XPH

Allworth Financial's XPH Position: Q2 2026 in Review

Allworth Financial held its State Street SPDR S&P Pharmaceuticals ETF (XPH) position steady in Q2 2026 at 790 shares worth $52.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2438.

Allworth Financial first reported a position in XPH in Q2 2017 and has held it in 37 quarters since. 93 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

  • Allworth Financial held 790 shares of State Street SPDR S&P Pharmaceuticals ETF worth $52.4K as of Q2 2026.
  • Allworth Financial left its State Street SPDR S&P Pharmaceuticals ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2438 holding.
  • Allworth Financial first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2017 and has held it in 37 quarters since.
  • 93 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.